NEW YORK, July 6, 2026
DarioHealth Corp. has announced a significant expansion of its digital health platform through a new agreement with a major health insurer in Arizona, secured via its strategic partnership with Amwell. The agreement provides Dario’s cardiometabolic digital health solution to the insurer’s Administrative Services Only (ASO) employer business, representing access to hundreds of thousands of covered lives. The milestone reinforces DarioHealth’s channel-led growth strategy, enabling the company to rapidly scale its clinically validated solutions among self-insured employers while strengthening its position in the rapidly growing digital therapeutics market. By leveraging Amwell’s established healthcare network and payer relationships, Dario aims to deliver personalized, behavior-driven care for individuals living with diabetes, hypertension, and weight management challenges, helping employers reduce healthcare costs while improving long-term clinical outcomes. The agreement also highlights the increasing adoption of digital health technologies that integrate personalized coaching, real-time data analytics, and evidence-based interventions to improve chronic disease management across large patient populations.
Strategic Partnership Expands Access to Cardiometabolic Digital Health
The newly announced agreement enables DarioHealth’s comprehensive cardiometabolic platform to become part of the insurer’s employer-focused ASO portfolio, allowing organizations to deploy personalized digital care programs based on the unique health needs of their workforce. The platform combines artificial intelligence-driven analytics, connected health technologies, behavioral coaching, and personalized interventions to support individuals managing type 2 diabetes, hypertension, obesity, and related chronic conditions. Employers can implement customized benefit strategies while providing employees with continuous monitoring, individualized coaching, and actionable health insights that encourage sustainable lifestyle changes.
The partnership reflects Dario’s strategy of utilizing established payer and healthcare networks rather than relying solely on direct customer acquisition, allowing the company to accelerate commercial expansion while reducing acquisition costs and improving operational efficiency. Through its expanding partnership ecosystem, Dario now has potential access to more than 116 million covered lives, significantly increasing opportunities for future adoption across employer-sponsored health plans.
Clinical Evidence Demonstrates Strong Health and Economic Outcomes
Advertisement
A key differentiator of DarioHealth’s digital therapeutics platform is its extensive body of clinical validation. The company reports that its solutions are supported by more than 100 scientific studies, including peer-reviewed publications and presentations at major scientific conferences, representing one of the largest collections of published clinical evidence among digital health companies. According to the company, a study funded by Sanofi demonstrated that employers using Dario’s platform achieved up to a fivefold return on investment (ROI) through improved management of chronic cardiometabolic conditions.
Clinical improvements observed among participants included reductions in hemoglobin A1C levels, systolic blood pressure, hyperglycemic events, and hospitalizations, ultimately contributing to lower total healthcare expenditures. By combining continuous remote monitoring with personalized behavioral coaching and predictive analytics, Dario delivers an integrated care model designed to improve patient engagement while generating measurable clinical and financial outcomes for employers and health plans alike.
Digital Therapeutics Continue Transforming Chronic Disease Management
The Arizona agreement further strengthens DarioHealth’s position as a leader in digital therapeutics, reflecting growing demand for scalable healthcare technologies capable of addressing the global burden of chronic disease. As healthcare systems increasingly prioritize value-based care, digital platforms that demonstrate measurable improvements in both patient outcomes and healthcare costs are becoming essential components of modern disease management strategies. Dario’s multi-condition platform extends beyond cardiometabolic care to include musculoskeletal health and behavioral health, enabling patients to receive coordinated, personalized support through a single digital ecosystem.
By integrating connected devices, real-time health data, artificial intelligence, and one-on-one coaching, the company continues to redefine how chronic diseases are managed outside traditional healthcare settings. The latest insurer partnership demonstrates how strategic collaborations with organizations such as Amwell can accelerate nationwide adoption of evidence-based digital health solutions while supporting more personalized, preventive, and cost-effective healthcare delivery.
Source: DarioHealth press release
